✦ LIBER ✦

Activity of Tipifarnib (R115777, Zarnestra™), a Farnesyl Transferase Inhibitor, in Previously Treated Metastatic Breast Cancer

✍ Scribed by Kavita Maung; Vinay K. Jain

Book ID: 117794009
Publisher: CIG Media Group, LP.
Year: 2002
Tongue: English
Weight: 99 KB
Volume: 3
Category: Article
ISSN: 1526-8209
DOI: 10.1016/s1526-8209(11)70173-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of a farnesyl transferase inhibit

Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinomain situof the breast in a human xenograft model and on breast and ovarian cancer cell growthin vitroandin vivo

✍ Fredrik Wärnberg, Daniel White, Elizabeth Anderson, Fiona Knox… 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 310 KB

Activity and toxicity of docetaxel (Taxo

Activity and toxicity of docetaxel (Taxotere®) in women with previously treated metastatic breast cancer

✍ Shapiro, J. D. ;Millward, M. J. ;Rischin, D. ;Davison, J. D. ;Michael, M. ;Franc 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB

663 - Activity of gemcltabine in metasta

663 - Activity of gemcltabine in metastatic breast cancer (MBC) patients previously treated with anthracycline-containlng regimens

✍ M. Spielmann; S. Kalla; A. Liombart-Cussac; M. Espié; M. Namer; J.M. Ferrero; C. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Clinical activity of cisplatin and prolo

Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: A phase II study

✍ Fried, Getta; Stein, Moshe E.; Haim, Nissim 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

Background. This phase II study evaluates the antitumor activity and tolerance of cisplatin and prolonged oral administration of etoposide in metastatic breast cancer previously exposed to anthracyclines. Procedure. Twenty-seven patients with metastatic breast cancer who developed tumor progression

Activity of Pemetrexed (ALIMTA®, Multita

Activity of Pemetrexed (ALIMTA®, Multitargeted Antifolate, LY231514) in Metastatic Breast Cancer Patients Previously Treated with an Anthracycline and a Taxane: An Interim Analysis

✍ Marc Spielmann; Miguel Martin; Moïse Namer; Andreas duBois; Clemens Unger; David 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 158 KB

A phase II trial of capecitabine in comb

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)

✍ Tianhong Li, Mengye Guo, William J. Gradishar, Joseph A. Sparano, Edith A. Perez 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 301 KB